S2Medical AB (publ) (S2M.ST)
SEK 0.01
(4.55%)
SEK 0.01
(4.55%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | - SEK | 0.0% |
| 2022 | - SEK | 0.0% |
| 2021 | - SEK | -100.0% |
| 2020 | 207.69 Thousand SEK | -75.0% |
| 2019 | 830.77 Thousand SEK | -46.02% |
| 2018 | 1.53 Million SEK | 2465.23% |
| 2017 | 60 Thousand SEK | 0.0% |
| 2016 | - SEK | -100.0% |
| 2015 | 3 Million SEK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - SEK | 0.0% |
| 2024 Q2 | - SEK | 0.0% |
| 2023 Q3 | - SEK | 0.0% |
| 2023 Q1 | - SEK | 0.0% |
| 2023 Q2 | - SEK | 0.0% |
| 2023 FY | - SEK | 0.0% |
| 2023 Q4 | - SEK | 0.0% |
| 2022 Q3 | - SEK | 0.0% |
| 2022 Q2 | - SEK | 0.0% |
| 2022 FY | - SEK | 0.0% |
| 2022 Q4 | - SEK | 0.0% |
| 2022 Q1 | - SEK | 0.0% |
| 2021 Q3 | - SEK | 0.0% |
| 2021 FY | - SEK | -100.0% |
| 2021 Q4 | - SEK | 0.0% |
| 2021 Q2 | - SEK | -100.0% |
| 2021 Q1 | 52 Thousand SEK | -74.96% |
| 2020 FY | 207.69 Thousand SEK | -75.0% |
| 2020 Q1 | 675 Thousand SEK | -18.75% |
| 2020 Q2 | 519 Thousand SEK | -23.11% |
| 2020 Q3 | 363 Thousand SEK | -30.06% |
| 2020 Q4 | 207.69 Thousand SEK | -42.78% |
| 2019 Q4 | 830.77 Thousand SEK | -16.51% |
| 2019 FY | 830.77 Thousand SEK | -46.02% |
| 2019 Q3 | 995 Thousand SEK | -15.53% |
| 2019 Q2 | 1.17 Million SEK | -13.38% |
| 2019 Q1 | 1.36 Million SEK | -11.64% |
| 2018 Q1 | - SEK | -100.0% |
| 2018 Q4 | 1.53 Million SEK | 0.0% |
| 2018 FY | 1.53 Million SEK | 2465.23% |
| 2018 Q2 | 75 Thousand SEK | 0.0% |
| 2017 Q2 | - SEK | 0.0% |
| 2017 FY | 60 Thousand SEK | 0.0% |
| 2017 Q4 | 60 Thousand SEK | -97.83% |
| 2017 Q3 | 2.76 Million SEK | 0.0% |
| 2017 Q1 | - SEK | 0.0% |
| 2016 FY | - SEK | -100.0% |
| 2015 FY | 3 Million SEK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AddLife AB (publ) | 2.53 Billion SEK | 100.0% |
| Biotage AB (publ) | 150 Million SEK | 100.0% |
| Bonesupport Holding AB (publ) | 13.22 Million SEK | 100.0% |
| Doxa AB (publ) | 3.6 Million SEK | 100.0% |
| Elekta AB (publ) | 4.8 Billion SEK | 100.0% |
| iZafe Group AB (publ) | 279 Thousand SEK | 100.0% |
| Ortivus AB (publ) | 3.57 Million SEK | 100.0% |
| Ortivus AB (publ) | 3.57 Million SEK | 100.0% |
| Q-linea AB (publ) | 12.9 Million SEK | 100.0% |
| Synsam AB (publ) | 2.02 Billion SEK | 100.0% |